Compare · CAH vs HKPD
CAH vs HKPD
Side-by-side comparison of Cardinal Health Inc. (CAH) and Cellyan Biotechnology Co. Ltd (HKPD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CAH and HKPD operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- CAH is the larger of the two at $53.41B, about 3538.2x HKPD ($15.1M).
- Over the past year, CAH is up 45.9% and HKPD is down 72.7% - CAH leads by 118.5 points.
- CAH has been more active in the news (3 items in the past 4 weeks vs 2 for HKPD).
- CAH has more recent analyst coverage (25 ratings vs 0 for HKPD).
- Company
- Cardinal Health Inc.
- Cellyan Biotechnology Co. Ltd
- Price
- $228.06+1.02%
- $0.35-2.64%
- Market cap
- $53.41B
- $15.1M
- 1M return
- -2.17%
- -5.79%
- 1Y return
- +45.87%
- -72.66%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 3
- 2
- Recent ratings
- 25
- 0
Cardinal Health Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Latest CAH
- Cardinal Health expands home care business with two tuck-in acquisitions
- Cardiovascular Logistics Names Dr. Gary Kirsh Chief Executive Officer
- Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11
- SEC Form 11-K filed by Cardinal Health Inc.
- SEC Form 11-K filed by Cardinal Health Inc.
- SEC Form SD filed by Cardinal Health Inc.
- Cardinal Health Board of Directors Approves Quarterly Dividend
- SEC Form 10-Q filed by Cardinal Health Inc.
- Cardinal Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook
Latest HKPD
- SEC Form 6-K filed by Cellyan Biotechnology Co. Ltd
- Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
- SEC Form EFFECT filed by Cellyan Biotechnology Co. Ltd
- SEC Form F-3 filed by Cellyan Biotechnology Co. Ltd
- SEC Form 3 filed by new insider Chan Kam Leung
- New insider Wong Lap Sun claimed ownership of 18,468 units of Class A Ordinary Shares (SEC Form 3)
- SEC Form 3 filed by new insider Wang Zifeng
- SEC Form 3 filed by new insider Liu Shu
- SEC Form 3 filed by new insider Zhou Mike Yao
- SEC Form 3 filed by new insider Wu Jingyan